Amyloid Beta Reference Antibody (solanezumab)

Amyloid-beta precursor protein {ECO:0000312|HGNC:HGNC:620}, APP {ECO:0000312|HGNC:HGNC:620}, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-secretase C-terminal fragment, Beta-CTF, Amyloid-beta protein 42, Abeta42, Beta-APP42, Amyloid-beta protein 40, Abeta40, Beta-APP40, C83, Alpha-secretase C-terminal fragment, Alpha-CTF, P3 (42), P3 (40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, AICD-59, AID (59), Gamma-CTF (59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, AICD-57, AID (57), Gamma-CTF (57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID (50), Gamma-CTF (50), C31, APP (HGNC:620)